[1]
Gil, A., Reyes Abad, M., Alerany, C., Alsina, L., López Granados, E., Neth, O., Poveda, J.L., Rivière, J.G., Rodríguez-Gallego, C., Tutein Nolthenius, J.B., Figueiredo , R. and Subías Labazuy , S. 2024. Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders. Global and Regional Health Technology Assessment. 11, 1 (May 2024), 124–130. DOI:https://doi.org/10.33393/grhta.2024.3041.